Abstract
Summary: A 7-week-old infant with methylmalonic acidemia had pancytopenia and hypoplastic bone marrow. The patient responded to large doses of vitamin B12 treatment, and within 3 wk, the blood counts and bone marrow cellularity returned to normal. To understand the mechanism of marrow depression in this infant, we examined the effect of the patient's plasma and methylmalonic acid itself on the in vitro growth of bone marrow-committed stem cells. The patient's plasma obtained before B12 treatment completely inhibited the marrow cell growth, whereas the posttreatment plasma showed no inhibition. Methylmalonic acid when added to the culture dishes in concentrations comparable to those reported in plasma of methylmalonic acidemia patients, inhibited growth of marrow stem cells in a concentration-dependent fashion. On the other hand, 16 to 18 hr incubation of cells in the same concentration of methylmalonic acid did not affect the recovery or viability of the cells. The observations suggest that methylmalonic acid is inhibitory to the proliferation of marrow stem cells. The mechanism of inhibition is yet to be elucidated.
Speculation: MMA at a concentration comparable to that reported in patients with methylmalonic acidemia inhibited in vitro growth of marrow hemopoietic cells, but overnight incubation of the cells in MMA at the same concentration did not reduce the number of viable cells determined by the trypan blue dye exclusion test. It appears, therefore, that MMA within the range of concentration tested is not immediately cytotoxic. Its inhibitory action thus seems to require longer cell contact hours than the 16 to 18 hr we used, and it may be directed against rapidly proliferating cell population. The potential mechanisms of inhibition are unknown and more work is needed to understand the interaction of MMA with hemopoietic cells.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Inoue, S., Krieger, I., Sarnaik, A. et al. Inhibition of Bone Marrow Stem Cell Growth In Vitro by Methylmalonic Acid: a Mechanism for Pancytopenia in a Patient with Methylmalonic Acidemia. Pediatr Res 15, 95–98 (1981). https://doi.org/10.1203/00006450-198102000-00001
Issue date:
DOI: https://doi.org/10.1203/00006450-198102000-00001
Keywords
This article is cited by
-
Severe anemia in patients with Propionic acidemia is associated with branched-chain amino acid imbalance
Orphanet Journal of Rare Diseases (2021)
-
Haematological findings in children with inborn errors of metabolism
Journal of Inherited Metabolic Disease (2006)
-
Liposomal amphotericin-B (AmBisome) for treatment of cutaneous widespread candidosis in an infant with methylmalonic acidaemia
European Journal of Pediatrics (1993)
-
Immune functions in methylmalonicaciduria
Journal of Inherited Metabolic Disease (1984)
